Data / Drug companies / Rising Pharma Holdings, Inc.

Rising Pharma Holdings, Inc.: 190 products in the FDA NDC directory, labeler code 64980

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Rising Pharma Holdings, Inc. (labeler code 64980) lists 190 products in the FDA National Drug Code Directory, covering 84 finished drugs by generic name. By type: 188 prescription drugs, 2 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 30, 2026.

The request: Watch Rising Pharma Holdings, Inc. (FDA labeler code 64980): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code

64980

Products in commercial distribution

190

Packages

355

Finished drugs by generic name

84

Prescription products

188

Over the counter products

2

Controlled substance products

Schedule II 3, Schedule IV 6, Schedule V 8

Flagged as original packager

171 of 171 products that carry the flag

Started marketing in the last 12 months

26

Products with a marketing end date set

3

Earliest marketing start

September 20, 2004

openFDA record search

api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Products by type

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.